Blood and Marrow Transplant Clinical Trials Network State of the Science Symposium 2007.
Outcomes of hematopoietic cell transplantation are steadily improving. New techniques have reduced transplant toxicities, and there are new sources of hematopoietic stem cells from unrelated donors. In June 2007 the Blood and Marrow Transplant Clinical Trials Network convened a State of the Science Symposium of more than 200 participants in Ann Arbor to identify the most compelling clinical research opportunities in the field. This report summarizes the symposium's discussions and identifies eleven high priority clinical trials that the network plans to pursue over the course of the next several years.
Ferrara
James L M
JL
University of Michigan, Ann Arbor, Michigan, USA. ferrara@umich.edu
Anasetti
Claudio
C
Stadtmauer
Edward
E
Antin
Joseph
J
Wingard
John
J
Lee
Stephanie
S
Levine
John
J
Schultz
Kirk
K
Appelbaum
Frederick
F
Negrin
Robert
R
Giralt
Sergio
S
Bredeson
Christopher
C
Heslop
Helen
H
Horowitz
Mary
M
D000328:Adult; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D006085:Graft Survival; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods*; D006801:Humans; D014184:Transplantation, Homologous; D014481:United States